SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-616639
Filing Date
2016-06-08
Accepted
2016-06-08 16:07:33
Documents
8
Period of Report
2016-07-21
Effectiveness Date
2016-06-08

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d190941ddef14a.htm DEF 14A 949269
2 GRAPHIC g190941g27d75.jpg GRAPHIC 36272
3 GRAPHIC g190941g33v79.jpg GRAPHIC 9523
4 GRAPHIC g190941g67z10.jpg GRAPHIC 31000
5 GRAPHIC g190941g87i25.jpg GRAPHIC 55957
6 GRAPHIC g190941g95r43.jpg GRAPHIC 31225
7 GRAPHIC g190941g98j65.jpg GRAPHIC 29799
8 GRAPHIC g190941pcpg001.jpg GRAPHIC 10131
  Complete submission text file 0001193125-16-616639.txt   1231812
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36172 | Film No.: 161703643
SIC: 2836 Biological Products, (No Diagnostic Substances)